A Phase I-II Trial of Everolimus and Sorafenib in Patients With Recurrent High-Grade Gliomas
Phase of Trial: Phase I/II
Latest Information Update: 19 May 2017
At a glance
- Drugs Everolimus (Primary) ; Sorafenib (Primary)
- Indications Anaplastic astrocytoma; Astrocytoma; Glioblastoma; Glioma; Gliosarcoma; Oligodendroglioma
- Focus Adverse reactions; Therapeutic Use
- 26 Jan 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 06 Nov 2015 Status changed from recruiting to not yet recruiting, as reported by ClinicalTrials.gov.
- 05 Nov 2015 Planned initiation date changed from 1 Sep 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.